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Online Resource 1: 
 
ANTIBIOTIC GUIDELINES FOR NEUROSURGERY (NBT ANTIBIOTIC GUIDELINES JULY 2016) 
 
 
Antibiotic treatment regimen for patients with EVD-associated ventriculitis 
 
Table 1: Dosage according to CSF volume of distribution (baseline dosage) 
Antibiotic <normal normal moderately >normal markedly >normal 
vancomycin 5 mg 10 mg 15 mg 20 mg 
 
N/B: The table above serves as a guide for the intraventricular vancomycin (IVV) treatment in the preterm 
cohort, as it is used across the adult and paediatric population. Treatment is administered on an individual basis 
according to recommendations provided by the Medical Microbiologists and in discussion with the attending 
Consultant Neonatologist. The established dosing regimen in our patient cohort were 3mg, 5mg, 10mg and 
15mg. 
 
 
 
 
 
 
 
 
 
  
